Review
Open access
Jul 2026
From Mechanism to Clinic: Engineered Bacteria–Nanomaterial Hybrid Systems for Cancer Immunotherapy
Overall, these platforms offer a potentially powerful framework for precision cancer immunotherapy, however, successful clinical translation will require stronger evidence regarding safety, controllability, manufacturing consistency, and therapeutic efficacy.
Jia Lin, Ming An, Yuxin Dai et al.
· Research · 0 citations